Cost prediction models for the comparison of two groups
- 4 June 2001
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 10 (4) , 363-366
- https://doi.org/10.1002/hec.615
Abstract
For trial‐based economic evaluation where patient‐specific cost data are not routinely available, cost prediction models are commonly used to estimate total cost for each patient. Typically, multiple regression techniques are used on data from diagnosis‐matched, non‐trial patients (where patient‐level cost data are available) to model cost as a function of covariates that are observed on the trial subjects (e.g. length of hospital stay, procedures, etc.). The estimated beta coefficients provide a means of estimating the total cost for each patient in the trial. However, the variability of the beta coefficients due the measurement and sampling error is seldom included in the overall variance expression for mean costs by treatment group. In this paper we provide a method for estimating this variance and provide an example application Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 4 references indexed in Scilit:
- Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?American Heart Journal, 2000
- Generalisation from phase III clinical trials: survival, quality of life, and health economicsThe Lancet, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994